NO20023914L - Preparater for anvendelse for regulering av aktiviteten til parkingenet - Google Patents

Preparater for anvendelse for regulering av aktiviteten til parkingenet

Info

Publication number
NO20023914L
NO20023914L NO20023914A NO20023914A NO20023914L NO 20023914 L NO20023914 L NO 20023914L NO 20023914 A NO20023914 A NO 20023914A NO 20023914 A NO20023914 A NO 20023914A NO 20023914 L NO20023914 L NO 20023914L
Authority
NO
Norway
Prior art keywords
activity
preparations
regulating
parking network
novel
Prior art date
Application number
NO20023914A
Other languages
English (en)
Other versions
NO20023914D0 (no
Inventor
Hana Koutnikova
Alexis Brice
Alain Fournier
Laurent Pradier
Catherine Prades
Isabelle Arnould-Reguigne
Marie-Francoise Rosier-Montus
Olga Corti
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0001980A external-priority patent/FR2805266B1/fr
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Publication of NO20023914D0 publication Critical patent/NO20023914D0/no
Publication of NO20023914L publication Critical patent/NO20023914L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20023914A 2000-02-17 2002-08-16 Preparater for anvendelse for regulering av aktiviteten til parkingenet NO20023914L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0001980A FR2805266B1 (fr) 2000-02-17 2000-02-17 Compositions utilisables pour reguler l'activite de la parkine
US19848900P 2000-04-18 2000-04-18
PCT/FR2001/000461 WO2001060857A2 (fr) 2000-02-17 2001-02-15 Compositions utilisables pour reguler l'activite de la parkine

Publications (2)

Publication Number Publication Date
NO20023914D0 NO20023914D0 (no) 2002-08-16
NO20023914L true NO20023914L (no) 2002-10-11

Family

ID=26212182

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023914A NO20023914L (no) 2000-02-17 2002-08-16 Preparater for anvendelse for regulering av aktiviteten til parkingenet

Country Status (14)

Country Link
US (2) US7132396B2 (no)
EP (1) EP1259606B1 (no)
KR (1) KR100811926B1 (no)
AT (1) ATE466083T1 (no)
AU (1) AU2001235696A1 (no)
BR (1) BR0108376A (no)
CA (1) CA2400256C (no)
CY (1) CY1111004T1 (no)
DE (1) DE60141948D1 (no)
IL (3) IL151211A0 (no)
MX (1) MXPA02007869A (no)
NO (1) NO20023914L (no)
NZ (1) NZ520802A (no)
WO (1) WO2001060857A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003051902A1 (en) * 2001-12-14 2003-06-26 Incyte Genomics, Inc. Neurotransmission-associated proteins
US7927786B2 (en) * 2003-02-18 2011-04-19 Cedars-Sinai Medical Center Parkin interacting polypeptides and methods of use
PL2195645T3 (pl) * 2007-09-11 2014-12-31 Cancer Prevention & Cure Ltd Metoda wspomagająca diagnostykę i terapię astmy i rak płuc
CN109297780B (zh) * 2018-10-23 2021-01-01 东华理工大学 一种液塑限联合测定法中的取样方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2449501A (en) * 1999-12-21 2001-07-03 Incyte Genomics, Inc. Vesicle trafficking proteins
WO2001053312A1 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
US20030220240A1 (en) * 2000-12-21 2003-11-27 Tang Y. Tom Vesicle trafficking proteins

Also Published As

Publication number Publication date
US7132396B2 (en) 2006-11-07
IL193310A (en) 2011-12-29
EP1259606A2 (fr) 2002-11-27
NO20023914D0 (no) 2002-08-16
KR100811926B1 (ko) 2008-03-10
CA2400256A1 (fr) 2001-08-23
US8273548B2 (en) 2012-09-25
AU2001235696A1 (en) 2001-08-27
ATE466083T1 (de) 2010-05-15
DE60141948D1 (de) 2010-06-10
IL193310A0 (en) 2011-08-01
EP1259606B1 (fr) 2010-04-28
CY1111004T1 (el) 2015-06-11
IL151211A (en) 2010-05-31
CA2400256C (fr) 2014-09-09
US20020155577A1 (en) 2002-10-24
US20060287230A1 (en) 2006-12-21
MXPA02007869A (es) 2003-02-10
IL151211A0 (en) 2003-04-10
BR0108376A (pt) 2003-03-11
KR20020089352A (ko) 2002-11-29
WO2001060857A2 (fr) 2001-08-23
NZ520802A (en) 2005-02-25
WO2001060857A3 (fr) 2002-06-20

Similar Documents

Publication Publication Date Title
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
DZ3197A1 (fr) Acides aminés bicycliques utilises comme agents pharmaceutiques.
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
AUPP589598A0 (en) Novel peptides
BR0312521A (pt) Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado
WO2004054607A3 (de) Stabile therapeutische proteine
WO2001012661A3 (en) RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-xL FUSION PROTEIN INHIBITS APOPTOSIS
PT1079849E (pt) Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica
PT1024809E (pt) Utilizacao de agentes de imunomodulacao
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
NO980296L (no) Forbedrede terapeutiske midler
AU7216498A (en) Inhibitors of the urokinase receptor
EP1023906A4 (en) POTENTIATOR FOR ANTI-TUMOR ANTIBODY LYMPHOID
ATE390440T1 (de) Neuroaktive peptide
EP0780472A3 (en) Stress proteins
DK0942743T3 (da) Topisk præparat til indføring af peptid-farmaka i levende organismer
DE60032161D1 (de) P-glycoproteine und ihre verwendungen
AU2001249267A1 (en) Methods and compositions for elucidating protein expression profiles in cells
ATE299704T1 (de) Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril
WO2000042063A3 (de) Peptide zur inhibierung von hbv-core-proteinen
WO2000000509A3 (en) Peptides for inhibiting hpv e7 proteins
ES2122912A1 (es) Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
WO2002077276A3 (en) Novel signalling polypeptide
WO2003059374A3 (de) Verwendung von dimer-spezifischen nuklear-lokalisations-signalpeptiden (dsnls) abgeleitet aus der stat dna bindungsdomäne

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application